文献速递心脏核医学肿瘤 PET/CT放射性药物与辐射防护

氟化钠在心血管疾病中的应用:一项系统综述

Sodium fluoride in cardiovascular disorders: A systematic review.
PubMed 文献 · J Nucl Cardiol · 2019-08-06

本系统综述评估了18F-氟化钠PET在心血管疾病中的临床研究。在动脉粥样硬化中,多数研究显示其摄取与心血管危险因素负担和血管钙化呈正相关,在冠状动脉和颈动脉的罪犯斑块/破裂部位摄取更高,并与组织学和血管内成像的高危特征相关。在主动脉瓣狭窄中,示踪剂摄取随疾病严重程度增加。结论认为氟化钠PET是识别高危斑块的有前景的无创技术,但需进一步前瞻性证据证明其预测临床事件、调整治疗策略和改善患者结局的价值。

要点

  • 18F-氟化钠PET摄取与心血管危险因素负担和血管钙化正相关。
  • 冠状动脉和颈动脉罪犯斑块/破裂部位摄取更高,与高危组织学特征相关。
  • 主动脉瓣狭窄中示踪剂摄取随疾病严重程度增加。

核心结论

  • 氟化钠PET是识别高危斑块的有前景的无创技术,可能用于评估动脉粥样硬化进展和主动脉瓣狭窄退行性变。
  • 尚需进一步前瞻性证据证明该技术预测临床事件、调整治疗策略和改善患者结局的价值。

研究设计与样本

  • 系统综述,纳入表征该示踪剂在心血管疾病中应用的临床研究。

主要发现

  • 在动脉粥样硬化中,多数研究报告氟化钠摄取与心血管危险因素负担和血管钙化呈正相关。
  • 冠状动脉和颈动脉的罪犯斑块/破裂部位摄取更高,且与斑块组织学和血管内成像分析的高危特征相关。
  • 在主动脉瓣狭窄中,示踪剂摄取随疾病严重程度增加。

临床怎么用

  • 氟化钠PET可作为识别高危斑块和评估主动脉瓣狭窄严重程度的潜在无创工具,但目前证据尚不足以指导临床决策。

局限性

  • 需要进一步前瞻性证据证明该技术预测临床事件、调整治疗策略和改善患者结局的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 18-Fluorine sodium fluoride is a well-known radiotracer used for bone metastasis diagnosis. Its uptake correlation with cardiovascular (CV) risk was primarily suggested in oncological patients. Moreover, as a specific marker of microcalcification, it seems to correlate with CV disease progression and plaque instability. METHODS AND RESULTS: Our purpose was to systematically review clinical studies that characterized the use of this marker in CV conditions. In atherosclerosis, most studies report a positive correlation with the burden of CV risk factors and vascular calcification. A higher uptake was found in culprit plaques/rupture sites in coronary and carotid arteries and it was also linked to high-risk features in histology and intravascular imaging analysis of the plaques. In aortic stenosis, this tracer displayed an increasing uptake with disease severity. CONCLUSIONS: Sodium fluoride positron emission tomography is a promising non-invasive technique to identify high-risk plaques, which sets ground to a potential use of this tracer in evaluating atherosclerotic disease progression and degenerative changes in aortic valve stenosis. Nevertheless, there is a need for further prospective evidence that demonstrates this technique's value in predicting clinical events, adjusting treatment strategies, and improving patient outcomes.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Silva Mendes BI, Oliveira-Santos M, Vidigal Ferreira MJ, et al. Sodium fluoride in cardiovascular disorders: A systematic review. J Nucl Cardiol. 2019. PMID: 31388965. doi:10.1007/s12350-019-01832-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。